FDA reverses course, will review Moderna's mRNA flu vaccine

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot

Shares of Moderna rose Wednesday after the Food and Drug Administration reversed its earlier refusal and agreed to review the company's new flu vaccine, clearing a path that had appeared suddenly ...

Moderna Spikes After FDA’s About-Face on mRNA Flu Vaccine

Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.
The Cardiology Advisor

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.
Zacks Investment Research on MSN

Moderna stock jumps after FDA reverses course on flu shot

Shares of Moderna MRNA rose 6% on Wednesday after the company announced that the FDA agreed to review its regulatory filing seeking approval for its seasonal influenza vaccine, mRNA-1010. A final ...
WLRN

FDA reverses course on Moderna flu shot

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...
MedPage Today

Trump Pressures FDA on Vaccines; Obesity Drug May Shed Too Much; Texas Hospital Sued

Raw oysters harvested from British Columbia, Canada, in the past 2 months may be contaminated with norovirus, the FDA warned. HHS Secretary Robert F. Kennedy Jr. and musician Kid Rock appeared ...
Morning Overview on MSN

New mRNA flu shot proves 30%+ more powerful at stopping influenza A

Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial ...